Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. | Tonix Pharmaceuticals was ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...

The human papillomavirus (HPV) is a major source of cancer that’s now almost entirely preventable through vaccination. But ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

Fully 34.3% of surveyed adults said they had never heard of HPV, and 37.6% were not aware of the HPV vaccine, reported ...

Final plans are taking shape for Wilson Community College’s Biomanufacturing Education and Skills Training (BEST) Center of Eastern North Carolina. The College recently revealed architectural ...

Emma Karst of the Russell FFA chapter in Russell, Kansas, has been named a national finalist this year for the Beef ...

TK-HW, KC-YH, RH-ML, MS-HC, DK-HW, JF and W-KS were involved in acquisition of data and interpretation ... Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank ...

With the backing of a new special taxing district in De Soto, Oddo Development hopes to break ground on a mixed-housing ...

Merck’s stock is falling after a rare revenue miss, and the announcement of a $3 billion cost-cutting plan that will include layoffs.

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said Tuesday in its quarterly report. Merck, which is facing plummeting sales ...